NCT05645692 2026-04-29A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial CancerHoffmann-La RochePhase 2 Active not recruiting204 enrolled